Stock Earnings

Question 1

Quels sont les états financiers clés de Aridis Pharmaceuticals Inc ?

Accepted Answer

Selon le dernier état financier (Form-10K), Aridis Pharmaceuticals Inc a un total d'actifs de $14, un bénéfice net loss de $-30

Question 2

Quels sont les ratios financiers clés pour ARDS ?

Accepted Answer

Le ratio de liquidité de Aridis Pharmaceuticals Inc est 0.36, la marge nette est -1,000, les ventes par action sont de $0.15.

Question 3

Comment les revenus de Aridis Pharmaceuticals Inc sont-ils répartis par segment ou géographie ?

Accepted Answer

Currently Aridis Pharmaceuticals Inc data is not available.

Question 4

Aridis Pharmaceuticals Inc est-elle rentable ?

Accepted Answer

no, selon les derniers états financiers, Aridis Pharmaceuticals Inc a un bénéfice net loss de $-30

Question 5

Aridis Pharmaceuticals Inc a-t-elle des passifs ?

Accepted Answer

yes, Aridis Pharmaceuticals Inc a un passif de 38

Question 6

Combien d'actions en circulation Aridis Pharmaceuticals Inc a-t-elle ?

Accepted Answer

Aridis Pharmaceuticals Inc a un total d'actions en circulation de 27.03

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	22	3	1	1	1	2
Revenue Growth (YoY)	1,000%	200%	0%	0%	-50%	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	5	7	7	6	6	3
Research & Development	17	25	36	16	24	23
Operating Expenses	23	33	44	23	30	26
Other Non Operating Income (Expenses)	0	0	0	--	--	1
Pretax Income	-1	-30	-42	-22	-29	-22
Income Tax Expense	--	--	--	--	--	--
Net Income	-1	-30	-46	-22	-29	-23
Net Income Growth	-97%	-35%	109%	-24%	26%	-15%
Shares Outstanding (Diluted)	37.42	18.77	12.29	9.17	8.46	8.11
Shares Change (YoY)	111%	53%	34%	8%	4%	3%
EPS (Diluted)	-0.03	-1.61	-3.77	-2.44	-3.51	-2.89
EPS Growth	-98%	-56.99%	55%	-30%	21%	-17%
Free Cash Flow	-17	-29	-23	-20	-8	-24
Free Cash Flow Per Share	-0.45	-1.54	-1.87	-2.18	-0.94	-2.95
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	-966.66%	-4,200%	-2,200%	-2,900%	-1,200%
Profit Margin	-4.54%	-1,000%	-4,600%	-2,200%	-2,900%	-1,150%
Free Cash Flow Margin	-77.27%	-966.66%	-2,300%	-2,000%	-800%	-1,200%
EBITDA	0	-29	-42	-22	-29	-24
EBITDA Margin	0%	-966.66%	-4,200%	-2,200%	-2,900%	-1,200%
D&A For EBITDA	0	0	0	0	0	0
EBIT	0	-29	-42	-22	-29	-24
EBIT Margin	0%	-966.66%	-4,200%	-2,200%	-2,900%	-1,200%
Effective Tax Rate	--	--	--	--	--	--

Aridis Pharmaceuticals Inc (ARDS) Price